Skip to content
Recall Observatory FDA recall evidence

Drug product

Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03

D-0560-2022

January 14, 2022

Class II

Product summary

Firm
Aurobindo Pharma USA Inc.
Event
Event 89423
Status
Terminated
Classification
Class II
Quantity
115776 bottles
Official record key
drug-enforcement:D-0560-2022

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023

Distribution pattern: USA Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications